TechnoPhage, SA - From science to innovative biopharmaceuticals

TechnoPhage and SIMM signed a collaboration agreement

TechnoPhage and SIMM signed a collaboration agreement, announced at AICEP Portugal Global, involving a collaboration in both pre-clinical and future clinical studies of TA101 for the treatment of Rheumatoid Arthritis to market TA101 in the People's Republic of China.

Read here one article and here another article.

2019 events

Phage Futures Europe
Brussels, Belgium, September 25-26, 2019